Market revenue in 2023 | USD 6.3 million |
Market revenue in 2030 | USD 9.7 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Total laparoscopic hysterectomy (tlh) |
Fastest growing segment | Laparoscopic Supracervical Hysterectomy (LSH) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Total Laparoscopic Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy |
Key market players worldwide | Johnson & Johnson, The Cooper Companies Inc, B. Braun Medical, Karl Storz, Conmed Corp, RUDOLF Medical, LiNA, Richard Wolf, Utah Medical Products Inc, PURPLE SURGICAL MANUFACTURING LIMITED, Conkin Surgical Instruments, Laborie Medical Technologies, Bissinger, The O.R. Company, LSI Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine manipulation devices market will help companies and investors design strategic landscapes.
Total laparoscopic hysterectomy (tlh) was the largest segment with a revenue share of 38.1% in 2024. Horizon Databook has segmented the Australia uterine manipulation devices market based on total laparoscopic hysterectomy (tlh), laparoscopic supracervical hysterectomy (lsh), laparoscopically assisted vaginal hysterectomy (lavh), sacrocolpopexy covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing rate of hospitalization due to gynecology procedures, such as uterine fibroids, endometriosis, and other gynecological disorders, and the growing demand for minimally invasive surgical procedures in Australia are among the major factors expected to drive market growth over the forecast period. Uterine fibroids are one of the primary indications for uterine manipulation devices in Australia.
According to the Australian Institute of Health and Welfare 2024, endometriosis is the third leading cause of nonfatal disease burden (YLD) among women due to reproductive and maternal conditions (13%), after genital prolapse (52%) and polycystic ovarian syndrome (26%). Moreover, according to the Australian Burden of Disease Study, in 2023, there were 8,213 YLDs from endometriosis in Australia, a rate of 0.61 per 1,000 females. The disease burden due to endometriosis is highest among women aged 30–34 with a rate of 1.71 YLD per 1,000 women.
The growing demand for minimally invasive surgical procedures is a key factor driving the uterine manipulation devices market growth. Minimally invasive procedures, such as hysteroscopy and laparoscopy, are increasingly preferred by patients and healthcare providers due to their reduced risk of complications, faster recovery time, and minimal scarring. In addition, over 25,000 gynecological laparoscopy procedures are performed in Australia annually, according to the Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia uterine manipulation devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia uterine manipulation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account